Related Experiment Video
Updated: Nov 7, 2025

04:37
Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
814
The Role of the Proteasome in Platelet Function
Abed El-Hakim El-Kadiry1,2, Yahye Merhi1,2
1Laboratory of Thrombosis and Hemostasis, Montreal Heart Institute, Research Centre, Montreal, QC H1T 1C8, Canada.
International Journal of Molecular Sciences
|April 30, 2021
Summary
Platelets utilize the proteasome for protein degradation, crucial for their function and survival. This pathway, linked to NF-κB, offers new therapeutic targets for atherothrombotic diseases.
Area of Science:
- Hematology
- Cell Biology
- Molecular Medicine
Background:
- Platelets are anucleated cell fragments vital for hemostasis and thrombosis.
- Platelets possess limited protein synthesis capabilities but contain protein degradation machinery, including the proteasome.
- The precise role of the proteasome in platelet biology is not fully understood.
Purpose of the Study:
- To review the current literature on proteasome function in platelets.
- To elucidate the regulatory role of the proteasome in platelet viability and function.
- To explore the therapeutic potential of the proteasome-NF-κB axis in atherothrombotic diseases.
Main Methods:
- Literature review of studies investigating platelet proteasome function.
- Analysis of proteasome involvement in platelet signaling pathways.
- Examination of the interplay between the proteasome and the NF-κB pathway in platelets.
Main Results:
- The proteasome plays a significant role in regulating platelet viability and function.
- Platelet proteasome activity is coupled with the transcription factor NF-κB.
- This coupling represents a potential therapeutic target for cardiovascular diseases.
Conclusions:
- The proteasome is an important mediator of platelet function and survival.
- Targeting the proteasome-NF-κB pathway in platelets may offer novel therapeutic strategies for atherothrombotic conditions.
Related Concept Videos
Structure and Function of Platelets
2.3K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
2.3K
Formation of the Platelet Plug
8.0K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.0K
The Proteasome Structure
1.2K
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The proteasome is an...
1.2K
The Proteasome
9.4K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
9.4K
The Proteasome
1.3K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.3K
The Proteasome
3.9K
3.9K

